Benzodiazepine Use and Precautions

Introduction to Benzodiazepines

Benzodiazepines have an elimination half-life of 30-40 hours, acting primarily on the central nervous system via GABA-A receptors, and are used for anxiety disorders, seizures, REM sleep behavior disorder, and as part of chemical restraint protocols, as stated by the American Academy of Sleep Medicine 1, 2

The use of benzodiazepines can lead to potential side effects including sedation and drowsiness, cognitive impairment, respiratory depression (especially when combined with other CNS depressants), and potential for dependence and withdrawal, as cautioned by guidelines from the American Academy of Sleep Medicine 1, 2
Combining benzodiazepines with other CNS depressants is not recommended due to the potential for additive effects, as advised by the American Heart Association 3, 2

Patients with respiratory conditions require careful monitoring when using benzodiazepines, as recommended by the American Academy of Sleep Medicine 1
The American Heart Association's 2023 guidelines do not list the combination of benzodiazepines and other CNS depressants as concerning for life-threatening toxicity due to poisoning 3

Contraindications for benzodiazepines include severe respiratory insufficiency, severe liver disease, myasthenia gravis, and sleep apnea, as stated by the American Academy of Sleep Medicine 4, 1
A gradual reduction of approximately 25% every 1-2 weeks is recommended to minimize withdrawal symptoms, with a strength of evidence supported by the American Academy of Sleep Medicine 5, 1, 6, 7

Common withdrawal symptoms include rebound insomnia, anxiety, irritability, tremors, and sweating, and if withdrawal symptoms become problematic, consider slowing the taper or returning to the previous dose temporarily before attempting a slower taper, as recommended by the American Academy of Sleep Medicine 6
The following table summarizes the management of withdrawal symptoms:

Gabapentin can be used for withdrawal management, with benefits including no abuse potential, fewer drug interactions, and the ability to help manage anxiety symptoms during withdrawal, starting with low doses (100-300 mg at bedtime or 100-300 mg three times daily) and gradually increased as tolerated, as suggested by the American Academy of Sleep Medicine 8

Alternatives to benzodiazepines for anxiety disorders include SSRIs, SNRIs, and buspirone, and for insomnia, non-benzodiazepine sleep aids, melatonin, or non-pharmacological approaches can be used, as recommended by the American Academy of Sleep Medicine 7, 9, 10, 11
Non-pharmacological approaches such as sleep hygiene optimization, cognitive behavioral therapy, and regular exercise (but not close to bedtime) may be considered for RLS management, as recommended by the American Academy of Sleep Medicine 12

Patients with polydrug use, a history of withdrawal seizures, significant medical comorbidities, or unstable psychiatric conditions should be referred to specialists, as recommended by the American Academy of Sleep Medicine 13, 14
The American Geriatrics Society recommends that benzodiazepines should only be used in older adults for alcohol or benzodiazepine withdrawal, severe acute anxiety, periprocedural sedation, or seizure disorders when other treatments have failed, with a strength of evidence supported by the American Geriatrics Society 15
Concurrent use of benzodiazepines and opioids should be avoided due to the risk of fatal overdose, as recommended by the American Academy of Sleep Medicine and other authorities 16, 17
Benzodiazepines can cause cognitive impairment, delirium, falls, and fractures in older adults, and should generally be avoided in this population, as recommended by the American Geriatrics Society 1, 18, 15